Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

SAN MATEO, Calif.: SAN MATEO, Calif., May 21, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, granted a stock option to a new employee as approved by the Compensation Committee of the Company's Board...

Click to view original post